-
公开(公告)号：EP3796916A1
公开(公告)日：2021-03-31
申请号：EP19737813.6
申请日：2019-05-23
申请人： Université Claude Bernard Lyon 1 , CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE -CNRS- , Ecole Normale Supérieure de Lyon , INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE - INSERM , Université Laval
-
公开(公告)号：EP3826671A1
公开(公告)日：2021-06-02
申请号：EP19758792.6
申请日：2019-07-12
申请人： Université Claude Bernard Lyon 1 , Centre National de la Recherche Scientifique (CNRS) , Ecole Normale Supérieure de Lyon , INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE - INSERM , Université Laval
发明人： ROSA-CALATRAVA, Manuel , BOIVIN, Guy , DUBOIS, Julia , PIZZORNO, Mario Andres , TERRIER, Olivier , HAMELIN, Marie-Eve , CAVANAGH, Marie-Hélène
IPC分类号： A61K39/12 , A61K39/155 , C12N7/04 , C12N15/86
-
公开(公告)号：EP3893928A1
公开(公告)日：2021-10-20
申请号：EP19842600.9
申请日：2019-12-12
申请人： Université Claude Bernard Lyon 1 , CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) , INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE - INSERM , Université Laval , TRANSGENE , Ecole Normale Supérieure de Lyon
-
公开(公告)号：EP4090334A1
公开(公告)日：2022-11-23
申请号：EP21704870.1
申请日：2021-01-12
申请人： Université Claude Bernard Lyon 1 , Institut National de la Santé et de la Recherche Médicale (INSERM) , Centre National de la Recherche Scientifique (CNRS) , Signia Therapeutics , Université Laval , Ecole Normale Supérieure de Lyon
发明人： TERRIER, Olivier , ROSA-CALATRAVA, Manuel , BOIVIN, Guy , PIZZORNO, Mario-Andres , PADEY, Blandine
IPC分类号： A61K31/554 , A61K31/5383 , A61K31/506 , A61K31/53 , A61K45/06 , A61P31/12 , A61P31/16 , A61K9/00
-
公开(公告)号：EP3270968A2
公开(公告)日：2018-01-24
申请号：EP16714789.1
申请日：2016-03-18
申请人： Université Claude Bernard Lyon 1 , Institut National de la Santé et de la Recherche Médicale (INSERM) , Hospices Civils De Lyon , Université Laval
IPC分类号： A61K45/06 , A61K31/137 , A61K31/215 , A61K31/554 , A61P31/16
CPC分类号： A61K31/554 , A61K9/007 , A61K31/137 , A61K31/215 , A61K31/24 , A61K31/35 , A61K31/704 , A61K31/7056 , A61K45/06 , A61K2300/00
摘要： The present invention relates to a pharmaceutical or veterinary composition for the use thereof in preventing and/or treating infection by the influenza viruses. Said composition is characterized in that it contains, in an appropriate pharmaceutical carrier, at least one compound selected from among Etilefrine and Diltiazem.
-
6.发明公开NUCLEIC ACID SEQUENCES FOR THE AMPLIFICATION AND DETECTION OF RESPIRATORY VIRUSES 审中-公开用于扩增和检测呼吸道病毒的核酸序列
公开(公告)号：EP2178897A1
公开(公告)日：2010-04-28
申请号：EP08783230.9
申请日：2008-07-17
申请人： Université Laval
发明人： BERGERON, Michel, G. , FRENETTE, Johanne , BOISSINOT, Maurice , BOIVIN, Guy , DIONNE, Natasha , LEBLANC, Eric
IPC分类号： C07H21/04 , C07H21/00 , C12N15/41 , C12N15/44 , C12N15/45 , C12N15/50 , C12P19/34 , C12Q1/68 , C12Q1/70 , C40B40/06
CPC分类号： C40B40/06 , C07B2200/11 , C12N7/00 , C12N2710/10322 , C12N2760/16122 , C12N2760/16222 , C12N2760/18322 , C12N2760/18522 , C12N2760/18622 , C12N2760/18722 , C12N2770/20022 , C12N2770/32322 , C12N2770/32722 , C12Q1/701 , C40B30/04
摘要： The present invention relates to methods of detection, as well as assays, reagents and kits for the specific detection of 15 clinically important respiratory viruses including influenza A and B viruses, human respiratory syncytial viruses, human metapneumoviruses, human enteroviruses, all serotypes of rhinoviruses, 7 serotypes of adenoviruses, parainfluenza viruses types 1, 2, 3, and 4, as well as coronaviruses NL, 229E, OC43, and SARS-CoV. The present invention allows for the detection of each of these respiratory viruses in a single assay.
-
7.发明公开
公开(公告)号：EP4358949A1
公开(公告)日：2024-05-01
申请号：EP22826929.6
申请日：2022-06-23
申请人： Université Laval
IPC分类号： A61K31/202 , A61K31/13 , A61K31/44 , A61K31/045 , A61K31/47 , A61K31/075 , A61K31/435 , A61K31/445 , A61K31/535 , A61K31/4965 , A61P31/12
CPC分类号： A61P31/12 , A61K31/202 , A61K31/13 , A61K31/47 , A61K31/232 , A61K31/133 , A61K31/4453 , A61K31/495 , A61K31/5375 , A61K31/352 , A61K31/165 , A61K31/047 , A61K31/10 , A61K31/085 , A61K31/4409
-
8.发明公开PAR1 INHIBITORS FOR USE IN THE TREATMENT OR PREVENTION OF PARAMYXOVIRIDAE INFECTIONS 审中-公开PAR1抑制剂FOR USE IN感染副粘病毒治疗或预防
公开(公告)号：EP2709630A1
公开(公告)日：2014-03-26
申请号：EP12782732.7
申请日：2012-05-11
IPC分类号： A61K31/5377 , A61K31/443 , A61K31/517 , A61P31/14 , A61K31/7088 , A61K39/395
CPC分类号： A61K31/4745 , A61K31/215 , A61K31/351 , A61K31/443 , A61K31/517 , A61K31/5377 , A61K31/7088 , A61K45/06 , A61K2300/00
摘要： The present invention is concerned with the use of Protease-Activated Receptor-1 (PAR1) inhibitors for preventing or treating a Paramyxoviridae infection in a subject. Described herein are methods, compounds and pharmaceutical compositions useful in addressing such infections, and more particularly infections from human respiratory syncytial virus (hRSV) and human metapneumovirus (hMPV).
-
-
-
-
-
-
-
搜索结果
8 条记录 (耗时 0.195 秒)
